Nakamoto Inc (NASDAQ: NAKA) issued 364,795,104 shares valued at $81.6M to buy BTC Inc and UTXO, adding $80.5M revenue and $40.1M net income; dilution flagged.Nakamoto Inc (NASDAQ: NAKA) issued 364,795,104 shares valued at $81.6M to buy BTC Inc and UTXO, adding $80.5M revenue and $40.1M net income; dilution flagged.

Nakamoto Inc issues 364.8M shares in BTC, UTXO deal

2026/02/21 11:19
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Nakamoto Inc issues 364.8M shares in BTC UTXO deal

Key Takeaways:

  • Nakamoto Inc acquired BTC Inc and UTXO, expanding its corporate footprint.
  • Deal places BTC Inc and UTXO under Nakamoto Inc ownership.
  • NAKA completed purchase of BTC Inc and UTXO, signaling strategic consolidation.

Nakamoto Inc (NASDAQ: NAKA) completed the all-stock acquisition of BTC Inc and UTXO Management GP, LLC, integrating a Bitcoin-focused media/events business with an investment manager, as reported by MarketScreener.

The combination brings operating businesses under Nakamoto’s umbrella and aligns with its stated focus on Bitcoin-native services across media, finance, and advisory.

According to Investing.com, the all-stock deal used a fixed $1.12 reference price, implying about $107.3 million in consideration at signing. At completion, the consideration equated to roughly $81.6 million on a market basis after option strikes, reflecting the decline in NAKA shares. The structure required issuing more than 360 million new shares, which materially dilutes existing shareholders.

As reported by StockTitan, BTC Inc and UTXO add about $80.5 million in revenue and $40.1 million in net income to Nakamoto on a trailing basis, indicating immediate earnings contribution subject to consolidation and integration.

Observers have highlighted related-party transaction optics and dilution concerns around using equity that had declined sharply. “Theater of the absurd,” said Jim Chanos, referencing the purchase of companies linked to the same founder, as reported by DL News.

At the time of this writing, Bitcoin traded around $67,675, based on data from Bitget. That backdrop may frame near-term sentiment and demand cycles for Bitcoin-native media and investment services.

Disclaimer: CoinLineup.com provides cryptocurrency and financial market information for educational and informational purposes only. The content on this site does not constitute financial, investment, or trading advice. Cryptocurrency and stock markets involve significant risk, and past performance is not indicative of future results. Always conduct your own research and consult a qualified financial advisor before making any investment decisions.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09